Inocras

Inocras is an AI-driven platform company that provides whole-genome insights to enable personalized treatment for cancer and rare diseases. Founded in 2020 by a team of physician-scientists, geneticists, and bioinformaticians, the company aims to improve patient diagnosis and treatment by fully unlocking the potential of genomic data. Since then, Inocras has developed IP-protected technologies and a proprietary whole-genome insight platform while achieving operational excellence in its CLIA-certified and CAP-accredited laboratory. The company also drives service innovation through patient-centered services, offering genetic counseling and clinical trial matching support.